Phibro Animal Health Corporation revised earnings guidance for the fiscal year ending June 30, 2023. For the period, the company expects net sales to be in the range of $960 million and $1 billion, net income to be in the range of $39 million and $43 million, from $45 million and $49 million and Diluted EPS to be in the range of $0.96 and $1.06, from $1.11 and $1.21.